Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06919692 · ClinicalTrials.gov registry record · NA
Maternal Left Lateral Position in Fetal Growth Restriction
A NA study of Fetal Growth Restriction, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT06919692: Recruiting NA study of Fetal Growth Restriction, sponsored by University of Colorado, Denver.
NCT06919692 is a NA study of Fetal Growth Restriction that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06919692, a NA study of Fetal Growth Restriction, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to learn if maternal left-lateral positioning in pregnancy works to treat fetal growth restriction. This study will also help us learn about the effects of left-lateral positioning on maternal metabolomics, maternal mental health, fetal cardiac function, and delivery outcomes. The main questions it aims to answer are: * Does maternal left-lateral position in a pregnancy with fetal growth restriction improve the baby's growth? * How are maternal metabolomics, delivery outcomes, maternal mental health, and fetal cardiac function impacted by maternal left-lateral position? Researchers will compare the intervention group to pregnancies with fetal growth restriction that receive standard of care (without left-lateral positioning) to see if left-lateral position improves fetal biometry in fetal growth restriction. Participants will: * Practice left-lateral position every day for 4 hours (cumulatively) with 10-mins stretching after every hour of left-lateral position, or continue to receive standard of care * Visit the clinic once after 4 weeks for a follow-up research visit, and at the time of delivery Tracking of the physical activity and adherence to left-lateral position at home in intervention group A will be done through a fitbit (smart watch) given during enrollment. A fitbit will also be given to participants in intervention group B, receiving standard of care, to monitor their physical activity trends at home.
Primary Outcome
Fetal estimated fetal weight and abdominal circumference will be assessed and compared to enrollment values
Conditions Studied
Interventions
- BEHAVIORAL Left lateral recumbent positioning
Study Locations (2)
Colorado
- UCHealth Prenatal Diagnosis and Genetics Clinic - Anschutz Medical Campus - Aurora
- CU John C. Hobbins Perinatal Center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-07-28 |
| Est. Completion | 2026-12-03 |
| Phase | NA |
What NCT06919692 shows while recruiting
NCT06919692 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Fetal Growth Restriction appearing as the primary indexed condition, and to 1 intervention - of which Left lateral recumbent positioning is the first listed.
NCT06919692 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06919692 about?
NCT06919692 is a clinical study titled "Maternal Left Lateral Position in Fetal Growth Restriction". The goal of this clinical trial is to learn if maternal left-lateral positioning in pregnancy works to treat fetal growth restriction. This study will also help us learn about the effects of left-lateral positioning on maternal metabolomics, maternal mental health, fetal cardiac function, and delive...
What is the current status of trial NCT06919692?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-07-28. Estimated completion is 2026-12-03.
What conditions does trial NCT06919692 study?
This clinical trial studies the following conditions: Fetal Growth Restriction.
What interventions are being tested in trial NCT06919692?
The interventions under investigation include: Left lateral recumbent positioning (BEHAVIORAL).
Who is sponsoring clinical trial NCT06919692?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06919692 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fetal Growth Restriction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06919692's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI